Serodiagnostic contributions of antibody titers against mycobacterial lipid antigens in mycobacterium avium complex pulmonary disease

Clinical Infectious Diseases

Volumn 49, Issue 4, 2009, Pages 529-535

  Nishimura, Tomoyasu ^a,c   Hasegawa, Naoki ^a   Fujita, Yukiko ^b   Yano, Ikuya ^b   Ishizaka, Akitoshi ^a  

^a KEIO UNIVERSITY   (Japan)

^b Kiyose   (Japan)

^c Department of Internal Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDOLIPID; IMMUNOGLOBULIN G ANTIBODY; LIPID; MYCOBACTERIUM ANTIGEN; TREHALOSE; TREHALOSE MONOMYCOLATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CORD FACTORS; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN G; LIPIDS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 67651086990     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600888     Document Type: Article

References (21)

1. American Thoracic Society, Medical Section of the American Lung Association. Diagnosis and treatment of disease caused by nontuber- culous mycobacteria. Am J Respir Crit Care Med 1997; 156:S1-25.
2. Griffith DE, Aksamit T, Brown-Elliott BA, et al., on behalf of the ATS Mycobacterial Diseases Subcommittee. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
3. Kitada S, Maekura R, Toyoshima N, et al. Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Clin Infect Dis 2002;35:1328-35.
4. Kitada S, Maekura R, Toyoshima N, et al. Use of glycopeptidolipid core antigen for serodiagnosis of Mycobacterium avium complex pulmonary disease in immunocompetent patients. Clin Diagn Lab Immunol 2005; 12:44-51.
5. Kitada S, Nishiuchi Y, Hiraga T, et al. Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease. Eur Respir J 2007;29:1217-23.
6. Kitada S, Kobayashi K, Ichiyama S, et al., for the MAC Serodiagnosis Study Group. Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med 2008; 177:793-7.
7. Fujita Y, Doi T, Maekura R, Ito M, Yano I. Differences in serological responses to specific glycopeptidolipid-core and common lipid antigens in patients with pulmonary disease due to Mycobacterium tuberculosis and Mycobacterium avium complex. J Med Microbiol 2006; 55:189-99.
8. Matsunaga I, Komori T, Ochi A, Mori N, Sugita M. Identification of antibody responses to the serotype-nonspecific molecular species of glycopeptidolipids in Mycobacterium avium infection. Biochem Bio- phys Res Commun 2008;377:165-9.
9. Barrow WW, Davis TL, Wright EL, Labrousse V, Bachelet M, Rastogi N. Immunomodulatory spectrum of lipids associated with Mycobac- terium avium serovar 8. Infect Immun 1995; 63:126-33.
10. Horgen L, Barrow EL, Barrow WW, Rastogi N. Exposure of human peripheral blood mononuclear cells to total lipids and serovar-specific glycopeptidolipids from Mycobacterium avium serovars 4 and 8 results in inhibition of TH1-type responses. Microb Pathog 2000;29:9-16.
11. Fujita Y, Naka T, Doi T, Yano I. Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 2005;151:1443-52.
12. Yoshikai Y. Immunological protection against Mycobacterium tuberculosis infection. Crit Rev Immunol 2006; 26:515-26.
13. Vankayalapati R, Wizel B, Samten B, et al. Cytokine profiles in im- munocompetent persons infected with Mycobacterium avium complex. J Infect Dis 2001; 183:478-84.
14. Herbert D, Paramasivan CN, Prabhakar R. Protective response in guinea pigs exposed to Mycobacterium avium intracellulare/M. scro- fulaceum, BCG &south Indian isolates of M. tuberculosis. Indian J Med Res 1994;99:1-7.
15. Kamala T, Paramasivan CN, Herbert D, Venkatesan P, Prabhakar R. Immune response &modulation of immune response induced in the guinea-pigs by Mycobacterium avium complex (MAC) &M. fortuitum complex isolates from different sources in the south Indian BCG trial area. Indian J Med Res 1996; 103:201-11.
16. Middleton AM, Chadwick MV, Nicholson AG, Dewar A, Feldman C, Wilson R. Investigation of mycobacterial colonisation and invasion of the respiratory mucosa. Thorax 2003;58:246-51.
17. Moore EH. Atypical mycobacterial infection in the lung: CT appearance. Radiology 1993; 187:777-82.
18. Fujita J, Ohtsuki Y, Suemitsu I, et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracel- lulare complex disease. Eur Respir J 1999; 13:535-40.
19. Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J. Successive follow-up of chest computed tomography in patients with Mycobac- terium avium-intracellulare complex. Respir Med 1999; 93:11-5.
20. Fujita J, Ohtsuki Y, Shigeto E, et al. Pathological findings of bron- chiectases caused by Mycobacterium avium intracellulare complex. Res- pir Med 2003; 97:933-8.
21. Ashino Y, Guio H, Iwamoto A, Yano I, Matsumura T, Hattori T. Se- rological response against Mycobacterium avium complex glycolipid antigens in patients with acquired immunodeficiency syndrome. Microbiol Immunol 2008; 52:36-9.